Francis S. Morrison MD—Tribute to an apheresis leader
Journal of Clinical Apheresis · 2023
DOI: 10.1002/jca.22075 ↗Kurz gefasst
Historischer Beitrag in der Zeitschrift Journal of Clinical Apheresis, 2023. Verfasst von Walter Linz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Oklahoma Blood Institute/Our Blood Institute, Oklahoma City, Oklahoma, USA. Hauptthemen laut MEDLINE: Blood Component Removal. Die Arbeit nennt 2 Literaturangaben.
Abstract (Originalsprache)
Francis S. Morrison MD was among the early developers and promoters of the American Society for Apheresis (ASFA). His work was pivotal in creating a lasting institutional structure from which American apheresis medical practice would develop decades after his death. Francis Morrison is honored each year at the ASFA annual meeting as ASFA awards the Francis S. Morrison MD Memorial Award Lecture to an individual who stands out as among its most accomplished members. This tribute seeks to describe the person and the key accomplishments of Francis S. Morrison in the historical context of a time when the future of apheresis medicine was uncertain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Oklahoma Blood Institute/Our Blood Institute, Oklahoma City, Oklahoma, USA.
- Division of Hematology/Oncology, University of Mississippi, Jackson, Mississippi, USA.
- Departments of Pathology & Pediatrics, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.
Zitieren
APA
Linz, W., Thigpen, J. T., & Strauss, R. G. (2023). Francis S. Morrison MD—Tribute to an apheresis leader. Journal of Clinical Apheresis. https://doi.org/10.1002/jca.22075
Vancouver
Linz W, Thigpen JT, Strauss RG. Francis S. Morrison MD—Tribute to an apheresis leader. Journal of Clinical Apheresis. 2023. doi:10.1002/jca.22075
BibTeX
@article{Linz2023,
author = {Linz, Walter and Thigpen, James T and Strauss, Ronald G},
title = {Francis S. Morrison MD—Tribute to an apheresis leader},
journal = {Journal of Clinical Apheresis},
year = {2023},
doi = {10.1002/jca.22075}
}
EUVIMED